Immunopathogenesis of psoriasis: Recent insights on the role of adaptive and innate immunity

被引:39
作者
Bachelez, H
机构
[1] Hop St Louis, INSERM, U697, F-75475 Paris 10, France
[2] Hop St Louis, Dept Dermatol 1, F-75475 Paris, France
关键词
psoriasis; T lymphocyte; keratinocyte; TNF alpha;
D O I
10.1016/j.jaut.2005.09.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis is a frequent chronic inflammatory disorder involving mostly skin and joints. Its characteristic features in the skin consist of inflammatory changes in both dermis and epidermis, with abnormal keratinocytic differentiation and proliferation. In recent years, an important set of knowledge has been provided by works addressing the immunopathogenic mechanisms of the disease. Indeed, recent advances in the knowledge of mechanisms linking innate and adaptive immunity have led to reconsideration of the roles of key players in the pathogenesis of the disease. This review will focus on results from studies performed in vitro and in vivo in patients with psoriasis, and on lessons from recently designed animal models which are considered as the most relevant with respect to the human disease. Even more important, these insights provide a rational basis for the design of new therapeutic strategies aiming at the deletion or the down regulation of activated T cells, or at the suppression of pathogenic cytokines Such as TNF-alpha. Some of these new biotherapeutic tools have been successfully used in vivo in clinical trials, providing a confirmation of such concepts. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 41 条
[1]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[2]   Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4 [J].
Bachelez, H ;
Flageul, B ;
Dubertret, L ;
Fraitag, S ;
Grossman, R ;
Brousse, N ;
Poisson, D ;
Knowles, RW ;
Wacholtz, MC ;
Haverty, TP ;
Chatenoud, L ;
Bach, JF .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (01) :53-62
[3]  
Badger J, 1996, CLIN REV ALLERG IMMU, V14, P417
[4]   THE IMMUNOLOGY OF PSORIASIS [J].
BAKER, BS ;
FRY, L .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :1-9
[5]   KINETICS AND REGULATION OF HUMAN KERATINOCYTE STEM-CELL GROWTH IN SHORT-TERM PRIMARY EX-VIVO CULTURE - COOPERATIVE GROWTH-FACTORS FROM PSORIATIC LESIONAL T-LYMPHOCYTES STIMULATE PROLIFERATION AMONG PSORIATIC UNINVOLVED, BUT NOT NORMAL, STEM KERATINOCYTES [J].
BATACSORGO, Z ;
HAMMERBERG, C ;
VOORHEES, JJ ;
COOPER, KD .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :317-327
[6]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[7]   Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α [J].
Boyman, O ;
Hefti, HP ;
Conrad, C ;
Nickoloff, BJ ;
Suter, M ;
Nestle, FO .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05) :731-736
[8]   Novel IL-12 family members shed light on the orchestration of Th1 responses [J].
Brombacher, F ;
Kastelein, RA ;
Alber, G .
TRENDS IN IMMUNOLOGY, 2003, 24 (04) :207-212
[9]   CD8+ T-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND/OR V(BETA)13.1 GENES [J].
CHANG, JCC ;
SMITH, LR ;
FRONING, KJ ;
SCHWABE, BJ ;
LAXER, JA ;
CARALLI, LL ;
KURLAND, HH ;
KARASEK, MA ;
WILKINSON, DI ;
CARLO, DJ ;
BROSTOFF, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9282-9286
[10]   Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].
Chaudhari, U ;
Romano, P ;
Mulcahy, LD ;
Dooley, LT ;
Baker, DG ;
Gottlieb, AB .
LANCET, 2001, 357 (9271) :1842-1847